A team of investigators at the Universities of Würzburg and Marburg have succeeded, for the first time, in experimentally demonstrating that bacterial metabolites can increase the cytotoxic activity of specific immune cells and thus positively influence the efficiency of tumor therapies. Findings from the new study were published recently in Nature Communications.